Kandaswamy Veena Coothan, Asokan Devarajan, Kalaiselvi Periandavan, Varalakshmi Palaninathan
Department of Medical Biochemistry, Dr. ALM. Post Graduate Institute of Basic Medical Sciences, University of Madras, Taramani Campus, Chennai, 600 113, India.
Clin Exp Nephrol. 2007 Sep;11(3):196-201. doi: 10.1007/s10157-007-0477-4. Epub 2007 Sep 28.
This study was done to investigate the DNA binding ability of a diagnostic biomarker, 45-kDa calcium oxalate monohydrate (COM) binding protein, isolated from human kidney and its effect on transcription.
The 45-kDa COM binding protein was isolated and purified from human kidney. The subcellular localization of the protein and the amino acid composition of the protein were analyzed. Oxalate-binding activity in the presence or absence of DNA was determined. The possibility of forming DNA-protein adducts was checked by diethylaminoethyl (DEAE)-Sephadex column chromatography. The effect of the protein on in vitro transcription was also studied.
The isolated 45-kDa protein was found to be basic in nature and its AACompIdent analysis showed it to be related to known transcription factors. The protein was found to be present in kidney cytosol and nucleus. The decreased oxalate binding activity in the presence of the DNA, and the shift in the DEAE-Sephadex elution profile established the DNA-binding ability of the protein. The in vitro transcription assay demonstrated the repression effect of the protein on gene expression during hyperoxaluria.
Transcriptional repression by the 45-kDa COM binding protein in an in vitro transcription assay system was reduced in the presence of oxalate. Hence, altered expression of certain genes involved in the prognosis of urolithiasis might be mediated by this 45-kDa protein.
本研究旨在调查从人肾中分离出的一种诊断生物标志物——45 kDa 一水合草酸钙(COM)结合蛋白的 DNA 结合能力及其对转录的影响。
从人肾中分离并纯化 45 kDa COM 结合蛋白。分析该蛋白的亚细胞定位和氨基酸组成。测定有无 DNA 存在时的草酸结合活性。通过二乙氨基乙基(DEAE)-葡聚糖凝胶柱色谱法检查形成 DNA-蛋白质加合物的可能性。还研究了该蛋白对体外转录的影响。
分离出的 45 kDa 蛋白本质上呈碱性,其 AACompIdent 分析表明它与已知转录因子有关。发现该蛋白存在于肾细胞溶质和细胞核中。在有 DNA 存在时草酸结合活性降低,以及 DEAE-葡聚糖凝胶洗脱图谱的变化证实了该蛋白的 DNA 结合能力。体外转录试验证明该蛋白在高草酸尿症期间对基因表达有抑制作用。
在体外转录试验系统中,45 kDa COM 结合蛋白的转录抑制作用在有草酸盐存在时降低。因此,某些参与尿路结石预后的基因表达改变可能由这种 45 kDa 蛋白介导。